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Abstract It is known that mammalian rpS3 functions as a
DNA repair endonuclease and ribosomal protein S3. It was
also observed that several ribosomal proteins or DNA repair
enzymes are related to apoptosis. We report here a third func-
tion of rpS3, induction of apoptosis. The localization of green
£uorescent protein (GFP)-rpS3 is changed to the nuclear mem-
brane when lymphocytic cells undergo rpS3-induced apoptosis.
Transient expression of GFP-rpS3 activates caspase-8/caspase-
3 and sensitizes cytokine-induced apoptosis. Deletion analysis
reveals that the two functions of rpS3, DNA repair and apopto-
sis, use independent functional domains.
, 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Mammalian cells respond to DNA damage signals by acti-
vating cell cycle checkpoints which arrest the cell cycle, and
activating DNA repair systems, or inducing apoptosis. It is
well known that there must be a checkpoint regulator for
DNA repair and apoptosis during DNA damage responses
[1]. Apoptosis is characterized by distinct morphological and
biochemical changes that take place upon the activation of a
family of caspases, which require proteolytic processing upon
initiation of apoptosis [2]. Two major signaling pathways, the
mitochondria-dependent pathway and the mitochondria-inde-
pendent pathway, result in the activation of caspases [3,4]. In
the instructive apoptosis, death receptors that transmit apo-
ptosis signals by speci¢c death ligands play a central role.
These receptors can activate death caspases through the intra-
cellular death domain. Trimerization of these receptors is crit-
ical for recruitment of adapter molecules to initiate caspase
activation [5].
The ribosome is a large ribonucleoprotein machine that
synthesizes proteins from transcribed mRNA. It is well known
that ribosomes consist of a large and a small subunit and the
small subunit mediates the interactions between mRNA and
tRNAs [6]. Several ribosomal proteins have also been found
to play roles in the translational apparatus and other extra-
ribosomal functions [7], including induction of apoptosis [8,9],
suppression of tumors [10], regulation of development [11],
and DNA repair [12^17].
Interestingly, mammalian UV DNA repair endonuclease III
has a lyase activity, cleaves the phosphodiester bond within a
cyclobutane pyrimidine dimer and AP site, and has 100% se-
quence identity with rpS3 [12]. Drosophila rpS3 has an AP
lyase activity on abasic site DNAs [18,19], a DNA deoxyribo-
phosphodiesterase activity [20], and a DNA glycosylase activ-
ity on 8-oxoguanine [21]. RpS3 forms a part of the domain on
the ribosome where the initiation of translation occurs; it can
be cross-linked to the eukaryotic initiation factors eIF-2 and
eIF-3, and appears to be directly involved in the ribosome^
mRNA^aminoacyl tRNA interactions during protein synthe-
sis while locating in the decoding center [22]. Therefore, rpS3
seems to function both in translation and in DNA repair.
In this study, we demonstrate for the ¢rst time that rpS3
induces apoptosis whose signal is executed through the acti-
vation of caspase-8 followed by caspase-3 activation. More
importantly, this protein increases the proapoptotic potential
of cytokines. These data suggest that the DNA repair path-
way and apoptosis pathway might cross-talk via rpS3.
2. Materials and methods
2.1. Plasmids
RpS3 and its mutants were subcloned into pEGFP-C1 vector
(Clontech) in frame with GFP (green £uorescence protein), generating
GFP-rpS3 and various deletion mutants fused with GFP fusion genes.
2.2. Cell culture and transfection
MPC-11 (mouse plasmacytoma) B cells were cultured on 10 cm
plates in Dulbecco’s modi¢ed Eagle’s medium, supplemented with
10% fetal bovine serum (Gibco BRL). Jurkat human T cells were
cultured in RPMI, supplemented with 10% fetal bovine serum (Gibco
BRL). Cells were transfected using Superfect Transfection Reagent
(Qiagen), and lysed in lysis bu¡er containing 50 mM Tris^HCl (pH
7.5), 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate and
protease inhibitors (1 Wg/ml pepstatin, 1 Wg/ml phenylmethylsulfonyl
£uoride (PMSF), 5 Wg/ml leupeptin, 10 Wg/ml aprotinin) and sonicated
brie£y, followed by immunoblotting.
2.3. Antibodies and immunoblot analysis
Monoclonal antibodies against GFP epitope (Roche), caspase-3
(Santa Cruz Biotechnology) and caspase-8 (Upstate Biotechnology)
were used for apoptotic activity of rpS3. Polyclonal antibodies against
human rpS3 were purchased from BioInstitute, Korea University.
Cell extracts were lysed in lysis bu¡er containing 50 mM Tris^HCl
(pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate
and protease inhibitors (1 Wg/ml pepstatin, 1 Wg/ml PMSF, 5 Wg/ml
leupeptin, 10 Wg/ml aprotinin). Lysates were sonicated brie£y and
cleared by centrifugation. Proteins from total cell lysate were electro-
phoresed on 12% sodium dodecyl sulfate^polyacrylamide gel electro-
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phoresis (SDS^PAGE) and transferred to a nitrocellulose membrane
(Bio-Rad). Immunoblotting was performed using chemiluminescence
blotting substrate (Roche). Horseradish peroxidase-conjugated anti-
mouse IgG and anti-rabbit IgG (Roche) were used as secondary anti-
bodies.
For subcellular fractionation, cells were harvested, washed with
phosphate-bu¡ered saline (PBS) and taken up in bu¡er I containing
10 mM HEPES (pH 7.9), 10 mM NaCl, 0.1 mM EDTA, 1 mM
dithiothreitol (DTT) and protease inhibitors. After incubation on
ice for 15 min, plasma membranes were disrupted by adding 0.3%
Nonidet P-40 and mixed for 10 s. The nuclei were pelleted by centri-
fugation at 13 000 rpm for 1 min, and a cytoplasmic fraction (super-
natant) was recovered. After washing three times, the pellet was re-
suspended in bu¡er II (20 mM HEPES [pH 7.9], 0.5 mM EDTA, 0.5
mM EGTA, 0.4 M NaCl, 1 mM DTT, protease inhibitors). After
rocking for 30 min on ice, the samples were centrifuged for 15 min
at 4‡C to recover a nuclear fraction.
2.4. Detection of apoptosis
Apoptosis was detected by DNA fragmentation, £uorescence-acti-
vated cell sorting (FACS), and nuclear morphology assays. For FACS
analysis, detached cells were pooled and ¢xed overnight with 75%
ethanol in PBS at 4‡C. After rinsing three times with PBS, cells
were incubated for 30 min with 1 ml of PBS containing 0.1 mg of
RNase and 50 Wg of propidium iodide. A total of 1U104 cells were
then analyzed in a £ow cytometer (FACSCalibur; Becton Dickinson).
For microscopic observation of apoptotic cells, pEGFP-C1 and
other GFP fusion vectors were transiently transfected into MPC-11
cells in 6 cm plates using Superfect (Qiagen). Twenty-eight hours after
transfection, image was collected using a £uorescence microscope
(Zeiss).
For DNA fragmentation assays, cells were transfected using Super-
fect transfection reagent (Qiagen), and lysed using lysis bu¡er (5 mM
Tris^HCl [pH 8.0], 20 mM EDTA, 0.5% Triton X-100) and digestion
bu¡er (100 mM NaCl, 10 mM Tris^HCl [pH 8.0], 24 mM EDTA,
0.5% SDS, 0.2 mg/ml proteinase K). The DNA in the lysate was
precipitated with 2 volumes of 100% ethanol and 1 M ammonium
acetate. The DNA precipitate was resuspended in 30 Wl of TE (pH
8.0, 200 Wg/ml DNase-free RNase A). After incubation at 37‡C for 1 h,
the DNA was loaded onto a 2% agarose gel and electrophoresis was
conducted at 50 V for 4 h in 1UTris-acetate-EDTA (TAE) bu¡er.
The gel was stained with 2 Wg/ml ethidium bromide for 15 min, de-
stained with water for 1 h, and visualized under UV light.
3. Results
3.1. RpS3 is involved in apoptosis
DNA damage signals trigger two pathways; one is related
to the cell cycle checkpoint which arrests the cell cycle for
DNA repair and the other is related to apoptosis to avoid
carcinogenesis. Cells undergoing apoptosis show distinctive
morphological changes, including membrane blebbing, cyto-
plasmic and nuclear condensation, loss of microvilli, and for-
mation of apoptotic bodies [23]. Another biological hallmark
of apoptosis is the cleavage of chromosomal DNA into nucle-
osomal fragments that is performed by caspase-activating
DNase, a DNase which has an endonuclease function acti-
vated by caspase-3 [24]. Therefore it was of interest to study
the relationship between repair endonuclease activity and ap-
optotic endonuclease activity. Surprisingly, it has been re-
vealed that rpS3a, which is another ribosomal protein distinct
from rpS3, has a role in the apoptotic process [8]. RpS3 might
play a role in apoptosis either as a DNase or as a signal
mediator between DNA repair and apoptosis.
To assess the apoptotic e¡ect of rpS3, we performed DNA
fragmentation analysis. RpS3 was transfected into MPC-11
cells by liposome-mediated transfection, and total cell lysates
were prepared 26 h after transfection for the detection of
nucleosomal fragments. As shown in Fig. 1A, DNA fragmen-
tation analysis of MPC-11 lysates revealed that GFP-rpS3
induced fragmentation of chromosomes.
It was also con¢rmed that the nuclei of cells over-expressing
GFP-rpS3, which were stained with DAPI, were condensed or
fragmented in the manner of apoptotic cells (Fig. 1B). Among
green cells expressing GFP-rpS3, over 25^50% of the cells
underwent apoptosis, while 5% of the cells expressing GFP
were apoptotic (Fig. 1C). A similar apoptotic e¡ect was ob-
tained in human cell lines such as Jurkat but low in ¢bro-
blasts.
3.2. The localization of rpS3 under rpS3-induced apoptosis
Endogenous rpS3 is localized in the cytoplasm as a ribo-
somal protein, but also exists in the nuclei at a ratio of ap-
proximately 6:4 (Fig. 2A). To examine the change of subcel-
lular localization of rpS3 proteins, cells were transfected with
plasmids containing rpS3 (GFP-rpS3). In normal cells, the
expression of GFP-rpS3 fusion protein was mostly found in
the cytoplasm but a smaller amount is also found in the nuclei
(Fig. 2B, upper panels). When cells undergo rpS3-induced ap-
optosis, GFP-rpS3 was translocalized towards the nuclear
membrane (Fig. 2B, lower panels). Furthermore, the cells
that expressed GFP-rpS3 in the nuclei but still maintained
normal nuclei underwent apoptosis as time passed by (Fig.
2C), suggesting that translocation of GFP-rpS3 into nuclei
is important in rpS3-induced apoptosis.
3.3. RpS3 activates caspase-8 and caspase-3 as downstream
e¡ectors
How is apoptosis triggered by rpS3? It is well established
that the major downstream event of the apoptotic pathway is
Fig. 1. RpS3 is directly involved in apoptosis. A: RpS3 constructed
in pEGFP-C1 vector was expressed in MPC-11 cells for 26 h and
then the lysate was resolved by 2% agarose gel. Transfection of the
GFP expression vector (pEGFP-C1) containing GFP alone served
as a negative control (mock). B: GFP-rpS3 was transfected into
MPC-11 cells. Twenty-six hours after transfection, cells were ¢xed.
Shown are representative non-apoptotic GFP cells and apoptotic
GFP-rpS3 cells. Both GFP and GFP-rpS3 transfected cells were
stained with DAPI to detect nuclear fragmentation or condensation.
C: GFP and GFP-rpS3 were transfected to MPC-11 cells. After
26 h, the number of apoptotic cells was determined by £ow cytome-
try or £uorescence microscopy.
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composed of a caspase cascade which is initiated by the acti-
vation of caspase-8 followed by caspase-3 [25]. To elucidate
the downstream events of rpS3-induced apoptosis, Jurkat cells
were transfected with GFP-rpS3 then treated with z-DEVD-
fmk and z-IETD-fmk, which are direct inhibitors of caspase-3
and caspase-8, respectively. We found that both inhibitors
blocked rpS3-induced cell shrinkage, nuclear condensation
and fragmentation (Fig. 3A), indicating that the activities of
caspase-8 and caspase-3 are required for the apoptotic e¡ect
of rpS3 whose signal is transmitted from caspase-8 to caspase-
3. Similar results were obtained when rpS3-transfected cell
lysates were assayed with Ac-DEVD-AFC and Ac-IETD-
AFC, which are substrates of caspase-3 and caspase-8, respec-
tively (Fig. 3B).
Furthermore, immunoblotting with anti-caspase-8 antibody
showed that the active form of endogenous caspase-8 was
increased in rpS3-transfected cell lysates (Fig. 3C). In the
case of caspase-3, rpS3 also increased the active form of cas-
pase-3, suggesting that rpS3 acts upstream of the caspase-8/
caspase-3 pathway.
3.4. RpS3 is involved in the cytokine-mediated apoptosis
pathway
We then tested whether rpS3 is involved in the signal trans-
duction of cytokine-mediated apoptosis which has been exten-
sively investigated as a model of programmed cell death via
caspases-8 and -3. Fas ligand and tumor necrosis factor K
(TNFK) are known to trigger the downstream death signals
by the trimerization of death receptors, inducing the associa-
tion of death domains and the recruitment of Fas binding
molecules including FADD/MORT1 and caspase-8 [26].
Therefore, we tested the cell death rates of MPC-11 cells
with or without transient transfection of GFP-rpS3 upon
the induction of apoptosis by Fas ligand or TNFK. GFP-
rpS3 enhances apoptosis synergistically in the presence of cy-
tokines (Fig. 4A), suggesting that rpS3-induced apoptosis
helps the cytokine-induced apoptosis pathway and increases
the sensitivity for cytokines. To further assess the localization
of rpS3 under cytokine-induced apoptosis, we have fraction-
ated cytosol or nucleus from cytokine-treated or non-treated
cells. In contrast to the cytokine-untreated cells, endogenous
rpS3 was translocated into the nuclei in cytokine-treated cells
(Fig. 4B), resulting in a change of the normal distribution
ratio of nuclear and cytoplasmic rpS3 proteins as shown in
Fig. 2A. This indicates that the translocation of rpS3 around
the nucleus is an important event in cytokine-induced apopto-
sis. It is to be noted that the translocation appears to be more
Fig. 2. Subcellular localization of rpS3 and apoptosis. A: MPC-11
cells were fractionated into cytosolic and nuclear fractions. Equal
volumes of cytosolic and nuclear fractions were analyzed by 12%
SDS^PAGE and immunoblotting with anti-rpS3 antibodies. Anti-
poly(ADP-ribose) polymerase antibodies were used as a control. B:
Twenty-six hours after transfection of GFP-rpS3, MPC-11 cells
were ¢xed and detected by their green £uorescence (green). Changes
of the chromatin structure in the cells were monitored by DAPI
staining (blue). C: Jurkat cells were transfected with pEGFP-rpS3.
At the time points indicated, cells were ¢xed and counted by £uo-
rescence microscopy. (For interpretation of the references to colour
in this ¢gure legend, the reader is referred to the web version of
this article.)
Fig. 3. RpS3 executes apoptosis via caspase-8 and caspase-3. A: Ef-
fect of the caspase inhibitors z-DEVD-fmk and z-IETD-fmk on the
induction of apoptosis by rpS3. Jurkat cells were transfected with
pEGFP-rpS3 (GFP-rpS3). Then 3 h after transfection, cells were
treated with dimethylsulfoxide carrier (mock) or 20 WM/ml z-DEVD
or z-IETD. After 25 h, the percentage of apoptosis was calculated
by counting the cells with fragmented nuclei among transfected cells
by £uorescence microscopy. B: Caspase activity in rpS3-induced ap-
optosis. Jurkat cells were transfected with pEGFP-rpS3. After 26 h,
cleavage of £uorogenic Ac-DEVD-AMC and Ac-IETD-AMC by
cell lysates was measured for 30 min using a £uorescent plate read-
er. C: Activation of procaspase-3 and procaspase-8. Following
pEGFP-rpS3 transfection, Jurkat cells were collected and lysed. Ly-
sates were examined by immunoblotting (IB) with anti-caspase-3 or
anti-caspase-8 antibodies. The positions of the procaspase-3 and
procaspase-8 precursors and active caspase-3 and caspase-8 are indi-
cated as arrows.
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signi¢cant in cells treated with TNFK than those with Fas
ligand.
3.5. RpS3 has distinct functional domains for DNA repair and
apoptosis
Like many other dual-function proteins, rpS3 may have
independent domains for DNA repair and apoptosis. To con-
¢rm this prediction, various deletion mutants of rpS3 were
constructed and apoptosis-inducing abilities were tested. De-
letion constructs encoding GFP-fused proteins were trans-
fected into MPC-11 cells to ¢nd the death-inducing domain
in rpS3. Mutants with C-terminal deletions (vC66, vC217)
that contain 177 and 26 amino acids respectively from the
N-terminus are believed to be defective in endonuclease activ-
ity as reported previously [27,28]. However, these proteins
showed a slightly increased apoptosis-inducing ability. Mu-
tants with N-terminal deletions also showed increased apopto-
tic ability until K18 was deleted (Fig. 5A). It is to be noted
that the domain with N-terminal 26 amino acids (vC217),
which is distinct from the endonuclease domain of rpS3, ap-
pears to be su⁄cient to induce apoptosis. In contrast, the
deletion mutant vN18 (v1^18 mutant) signi¢cantly reduced
the death-inducing ability, suggesting that 15^26 amino acids
of the N-terminus are critical for apoptosis. These results
imply that rpS3 has two independent domains, a repair do-
main which resides in the C-terminus [18,27,28] and a death-
inducing domain in the N-terminus (Fig. 5B). 4. Discussion
RpS3, a very well-conserved protein throughout eukary-
otes, with 78% amino acid similarity between S. cerevisiae
and humans, is an essential gene in yeast, as expected [29].
In humans, it is de¢nitely involved in DNA repair [12], im-
plying its role in the maintenance of the integrity of the hu-
man genome as well. As a ribosomal protein, it is also related
to translation, which seems to be a major function.
When cells are exposed to genotoxic stress, DNA damage
processing is initiated and repair or apoptosis of the cells is
determined. DNA damage-induced apoptosis seems to protect
organisms from cancer generation. Transcriptional activation
of p53 has been demonstrated to play a key role in the early
responses induced by DNA damage [30,31]. A DNA repair
enzyme might increase not only the rate of repair at the dam-
aged site but also the rate of apoptosis under severe damage
by acting as a signal mediator from repair to cell death [32].
Our study shows that ectopic expression of rpS3 protein in-
duces programmed cell death through the activation of cas-
pase-8 and caspase-3, indicating that rpS3 itself is a major
determinant of cell fate.
NM23-H1 was identi¢ed as a granzyme A-activated DNase
in a caspase-independent pathway during cytotoxic T lympho-
cyte-mediated apoptosis [33]. Granzyme A released from cy-
totoxic T lymphocytes promotes the cell death of target cells
by activation of NM23-H1 and inducing single-strand DNA
nicking. However, no other endonucleases responsible for
DNA nicking in caspase-dependent apoptosis pathways have
been identi¢ed in lymphocytes. Moreover, rpS3 mutants with
N- or C-terminal deletions increased the apoptosis-inducing
ability, suggesting that rpS3 might be activated by post-trans-
lational modi¢cation such as cleavage by serine proteases. It is
also possible that other types of modi¢cation induce rpS3 to
be involved in apoptosis.
Apoptosis, regulated by cytokines such as Fas ligand or
Fig. 4. RpS3 and its translocation enhance cytokine-induced apo-
ptosis. A: RpS3 sensitizes cytokine-induced apoptosis. GFP and
GFP-rpS3 were transfected to MPC-11 cells. After 24 h, cells were
treated with actinomycin D (100 ng/ml). After 2 h, cells were ex-
posed to Fas antibodies (100 ng/ml) or TNFK (30 ng/ml) for 6 h
and harvested for FACS analysis. The data shown are the average
of three independent experiments. B: Jurkat cells were exposed to
Fas antibodies (100 ng/ml) or TNFK (30 ng/ml) for 2 h, harvested
and fractionated into cytosol and nucleus. Fractions were examined
by immunoblotting (IB) with anti-rpS3 antibodies. The bottom pan-
el indicates a quantitation for the intensity of bands in the upper
panel.
Fig. 5. RpS3 has independent domains for DNA repair and apopto-
sis. A: MPC-11 cells were transfected with expression vectors for
GFP-fused rpS3 mutant proteins encoding N-terminal or C-terminal
deletions (vN14, 15^243 aa; vN18, 19^243 aa; vC30, 1^213 aa;
vC66, 1^177 aa; vC217, 1^26 aa). Apoptotic cells containing GFP-
fused rpS3 mutants were counted by £uorescence microscopy. B:
Schematic representation of human rpS3. The gray area represents
the N-terminal apoptotic domain. The black box indicates the C-ter-
minal amino acids which are su⁄cient for the repair endonuclease
activity of rpS3. There are domains, represented by blank boxes, in
both termini that appear to regulate apoptotic activities in a nega-
tive manner. KH domain is a highly conserved motif found in
RNA binding proteins.
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TNFK and caused by receptor-initiated signal transduction,
plays a critical role in lymphocyte development and homeo-
stasis. Moreover, it is well established that lymphocytes gain
antigen speci¢city by creating a unique antigen receptor
through the recombination of V, D, and J gene segments
[34]. This random somatic recombination makes lymphocytes
confront with genomic instability. For this reason, ATM-de-
¢cient mice develop thymic lymphomas with T cell receptor
translocations at a high frequency [35]. Therefore, the proa-
poptotic ability of rpS3 might be signi¢cantly sensitized in
lymphocytes.
This study demonstrates that rpS3 and its concurrent trans-
location towards the nucleus are an important event in apo-
ptosis. Therefore, rpS3 is likely to perform its dual function as
a repair enzyme and a signaling mediator of apoptosis.
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